Global BCG and Tuberculosis Vaccine Market Growth 2024-2031

Report ID: 1550545 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global BCG and Tuberculosis Vaccine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for BCG and Tuberculosis Vaccine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for BCG and Tuberculosis Vaccine by Country/Region, 2017, 2022 & 2028
    2.2 BCG and Tuberculosis Vaccine Segment by Type
        2.2.1 Immune Vaccine
        2.2.2 Therapy Vaccine
    2.3 BCG and Tuberculosis Vaccine Sales by Type
        2.3.1 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
        2.3.2 Global BCG and Tuberculosis Vaccine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global BCG and Tuberculosis Vaccine Sale Price by Type (2017-2022)
    2.4 BCG and Tuberculosis Vaccine Segment by Application
        2.4.1 Self-Procurement
        2.4.2 UNICEF
        2.4.3 Other
    2.5 BCG and Tuberculosis Vaccine Sales by Application
        2.5.1 Global BCG and Tuberculosis Vaccine Sale Market Share by Application (2017-2022)
        2.5.2 Global BCG and Tuberculosis Vaccine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global BCG and Tuberculosis Vaccine Sale Price by Application (2017-2022)
3 Global BCG and Tuberculosis Vaccine by Company
    3.1 Global BCG and Tuberculosis Vaccine Breakdown Data by Company
        3.1.1 Global BCG and Tuberculosis Vaccine Annual Sales by Company (2020-2022)
        3.1.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Company (2020-2022)
    3.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Company (2020-2022)
        3.2.1 Global BCG and Tuberculosis Vaccine Revenue by Company (2020-2022)
        3.2.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Company (2020-2022)
    3.3 Global BCG and Tuberculosis Vaccine Sale Price by Company
    3.4 Key Manufacturers BCG and Tuberculosis Vaccine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers BCG and Tuberculosis Vaccine Product Location Distribution
        3.4.2 Players BCG and Tuberculosis Vaccine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for BCG and Tuberculosis Vaccine by Geographic Region
    4.1 World Historic BCG and Tuberculosis Vaccine Market Size by Geographic Region (2017-2022)
        4.1.1 Global BCG and Tuberculosis Vaccine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Geographic Region
    4.2 World Historic BCG and Tuberculosis Vaccine Market Size by Country/Region (2017-2022)
        4.2.1 Global BCG and Tuberculosis Vaccine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global BCG and Tuberculosis Vaccine Annual Revenue by Country/Region
    4.3 Americas BCG and Tuberculosis Vaccine Sales Growth
    4.4 APAC BCG and Tuberculosis Vaccine Sales Growth
    4.5 Europe BCG and Tuberculosis Vaccine Sales Growth
    4.6 Middle East & Africa BCG and Tuberculosis Vaccine Sales Growth
5 Americas
    5.1 Americas BCG and Tuberculosis Vaccine Sales by Country
        5.1.1 Americas BCG and Tuberculosis Vaccine Sales by Country (2017-2022)
        5.1.2 Americas BCG and Tuberculosis Vaccine Revenue by Country (2017-2022)
    5.2 Americas BCG and Tuberculosis Vaccine Sales by Type
    5.3 Americas BCG and Tuberculosis Vaccine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC BCG and Tuberculosis Vaccine Sales by Region
        6.1.1 APAC BCG and Tuberculosis Vaccine Sales by Region (2017-2022)
        6.1.2 APAC BCG and Tuberculosis Vaccine Revenue by Region (2017-2022)
    6.2 APAC BCG and Tuberculosis Vaccine Sales by Type
    6.3 APAC BCG and Tuberculosis Vaccine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe BCG and Tuberculosis Vaccine by Country
        7.1.1 Europe BCG and Tuberculosis Vaccine Sales by Country (2017-2022)
        7.1.2 Europe BCG and Tuberculosis Vaccine Revenue by Country (2017-2022)
    7.2 Europe BCG and Tuberculosis Vaccine Sales by Type
    7.3 Europe BCG and Tuberculosis Vaccine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa BCG and Tuberculosis Vaccine by Country
        8.1.1 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2017-2022)
    8.2 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Type
    8.3 Middle East & Africa BCG and Tuberculosis Vaccine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of BCG and Tuberculosis Vaccine
    10.3 Manufacturing Process Analysis of BCG and Tuberculosis Vaccine
    10.4 Industry Chain Structure of BCG and Tuberculosis Vaccine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 BCG and Tuberculosis Vaccine Distributors
    11.3 BCG and Tuberculosis Vaccine Customer
12 World Forecast Review for BCG and Tuberculosis Vaccine by Geographic Region
    12.1 Global BCG and Tuberculosis Vaccine Market Size Forecast by Region
        12.1.1 Global BCG and Tuberculosis Vaccine Forecast by Region (2023-2028)
        12.1.2 Global BCG and Tuberculosis Vaccine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global BCG and Tuberculosis Vaccine Forecast by Type
    12.7 Global BCG and Tuberculosis Vaccine Forecast by Application
13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck BCG and Tuberculosis Vaccine Product Offered
        13.1.3 Merck BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Japan BCG Lab
        13.2.1 Japan BCG Lab Company Information
        13.2.2 Japan BCG Lab BCG and Tuberculosis Vaccine Product Offered
        13.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Japan BCG Lab Main Business Overview
        13.2.5 Japan BCG Lab Latest Developments
    13.3 Serum Institute of India
        13.3.1 Serum Institute of India Company Information
        13.3.2 Serum Institute of India BCG and Tuberculosis Vaccine Product Offered
        13.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Serum Institute of India Main Business Overview
        13.3.5 Serum Institute of India Latest Developments
    13.4 AJ Vaccines
        13.4.1 AJ Vaccines Company Information
        13.4.2 AJ Vaccines BCG and Tuberculosis Vaccine Product Offered
        13.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 AJ Vaccines Main Business Overview
        13.4.5 AJ Vaccines Latest Developments
    13.5 BioFarma
        13.5.1 BioFarma Company Information
        13.5.2 BioFarma BCG and Tuberculosis Vaccine Product Offered
        13.5.3 BioFarma BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 BioFarma Main Business Overview
        13.5.5 BioFarma Latest Developments
    13.6 GreenSignal Bio Pharma
        13.6.1 GreenSignal Bio Pharma Company Information
        13.6.2 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Offered
        13.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 GreenSignal Bio Pharma Main Business Overview
        13.6.5 GreenSignal Bio Pharma Latest Developments
    13.7 China National Biotec
        13.7.1 China National Biotec Company Information
        13.7.2 China National Biotec BCG and Tuberculosis Vaccine Product Offered
        13.7.3 China National Biotec BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 China National Biotec Main Business Overview
        13.7.5 China National Biotec Latest Developments
    13.8 Biomed Lublin
        13.8.1 Biomed Lublin Company Information
        13.8.2 Biomed Lublin BCG and Tuberculosis Vaccine Product Offered
        13.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Biomed Lublin Main Business Overview
        13.8.5 Biomed Lublin Latest Developments
    13.9 Taj Pharmaceuticals
        13.9.1 Taj Pharmaceuticals Company Information
        13.9.2 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Offered
        13.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Taj Pharmaceuticals Main Business Overview
        13.9.5 Taj Pharmaceuticals Latest Developments
    13.10 Ataulpho de Paiva
        13.10.1 Ataulpho de Paiva Company Information
        13.10.2 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Offered
        13.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Ataulpho de Paiva Main Business Overview
        13.10.5 Ataulpho de Paiva Latest Developments
    13.11 IVAC-Institute of Vaccines and Medical Biologicals
        13.11.1 IVAC-Institute of Vaccines and Medical Biologicals Company Information
        13.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Offered
        13.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 IVAC-Institute of Vaccines and Medical Biologicals Main Business Overview
        13.11.5 IVAC-Institute of Vaccines and Medical Biologicals Latest Developments
    13.12 Queen Saovabha Mem. Inst
        13.12.1 Queen Saovabha Mem. Inst Company Information
        13.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Offered
        13.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Queen Saovabha Mem. Inst Main Business Overview
        13.12.5 Queen Saovabha Mem. Inst Latest Developments
    13.13 Microgen
        13.13.1 Microgen Company Information
        13.13.2 Microgen BCG and Tuberculosis Vaccine Product Offered
        13.13.3 Microgen BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Microgen Main Business Overview
        13.13.5 Microgen Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. BCG and Tuberculosis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. BCG and Tuberculosis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Immune Vaccine
    Table 4. Major Players of Therapy Vaccine
    Table 5. Global BCG and Tuberculosis Vaccine Sales by Type (2017-2022) & (Units)
    Table 6. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
    Table 7. Global BCG and Tuberculosis Vaccine Revenue by Type (2017-2022) & ($ million)
    Table 8. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2017-2022)
    Table 9. Global BCG and Tuberculosis Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
    Table 10. Global BCG and Tuberculosis Vaccine Sales by Application (2017-2022) & (Units)
    Table 11. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
    Table 12. Global BCG and Tuberculosis Vaccine Revenue by Application (2017-2022)
    Table 13. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2017-2022)
    Table 14. Global BCG and Tuberculosis Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
    Table 15. Global BCG and Tuberculosis Vaccine Sales by Company (2020-2022) & (Units)
    Table 16. Global BCG and Tuberculosis Vaccine Sales Market Share by Company (2020-2022)
    Table 17. Global BCG and Tuberculosis Vaccine Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global BCG and Tuberculosis Vaccine Revenue Market Share by Company (2020-2022)
    Table 19. Global BCG and Tuberculosis Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
    Table 20. Key Manufacturers BCG and Tuberculosis Vaccine Producing Area Distribution and Sales Area
    Table 21. Players BCG and Tuberculosis Vaccine Products Offered
    Table 22. BCG and Tuberculosis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global BCG and Tuberculosis Vaccine Sales by Geographic Region (2017-2022) & (Units)
    Table 26. Global BCG and Tuberculosis Vaccine Sales Market Share Geographic Region (2017-2022)
    Table 27. Global BCG and Tuberculosis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global BCG and Tuberculosis Vaccine Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global BCG and Tuberculosis Vaccine Sales by Country/Region (2017-2022) & (Units)
    Table 30. Global BCG and Tuberculosis Vaccine Sales Market Share by Country/Region (2017-2022)
    Table 31. Global BCG and Tuberculosis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global BCG and Tuberculosis Vaccine Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas BCG and Tuberculosis Vaccine Sales by Country (2017-2022) & (Units)
    Table 34. Americas BCG and Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
    Table 35. Americas BCG and Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas BCG and Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
    Table 37. Americas BCG and Tuberculosis Vaccine Sales by Type (2017-2022) & (Units)
    Table 38. Americas BCG and Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
    Table 39. Americas BCG and Tuberculosis Vaccine Sales by Application (2017-2022) & (Units)
    Table 40. Americas BCG and Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
    Table 41. APAC BCG and Tuberculosis Vaccine Sales by Region (2017-2022) & (Units)
    Table 42. APAC BCG and Tuberculosis Vaccine Sales Market Share by Region (2017-2022)
    Table 43. APAC BCG and Tuberculosis Vaccine Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC BCG and Tuberculosis Vaccine Revenue Market Share by Region (2017-2022)
    Table 45. APAC BCG and Tuberculosis Vaccine Sales by Type (2017-2022) & (Units)
    Table 46. APAC BCG and Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
    Table 47. APAC BCG and Tuberculosis Vaccine Sales by Application (2017-2022) & (Units)
    Table 48. APAC BCG and Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
    Table 49. Europe BCG and Tuberculosis Vaccine Sales by Country (2017-2022) & (Units)
    Table 50. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
    Table 51. Europe BCG and Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
    Table 53. Europe BCG and Tuberculosis Vaccine Sales by Type (2017-2022) & (Units)
    Table 54. Europe BCG and Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
    Table 55. Europe BCG and Tuberculosis Vaccine Sales by Application (2017-2022) & (Units)
    Table 56. Europe BCG and Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Country (2017-2022) & (Units)
    Table 58. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa BCG and Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Type (2017-2022) & (Units)
    Table 62. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa BCG and Tuberculosis Vaccine Sales by Application (2017-2022) & (Units)
    Table 64. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of BCG and Tuberculosis Vaccine
    Table 66. Key Market Challenges & Risks of BCG and Tuberculosis Vaccine
    Table 67. Key Industry Trends of BCG and Tuberculosis Vaccine
    Table 68. BCG and Tuberculosis Vaccine Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. BCG and Tuberculosis Vaccine Distributors List
    Table 71. BCG and Tuberculosis Vaccine Customer List
    Table 72. Global BCG and Tuberculosis Vaccine Sales Forecast by Region (2023-2028) & (Units)
    Table 73. Global BCG and Tuberculosis Vaccine Sales Market Forecast by Region
    Table 74. Global BCG and Tuberculosis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas BCG and Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (Units)
    Table 77. Americas BCG and Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC BCG and Tuberculosis Vaccine Sales Forecast by Region (2023-2028) & (Units)
    Table 79. APAC BCG and Tuberculosis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe BCG and Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (Units)
    Table 81. Europe BCG and Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa BCG and Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (Units)
    Table 83. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global BCG and Tuberculosis Vaccine Sales Forecast by Type (2023-2028) & (Units)
    Table 85. Global BCG and Tuberculosis Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global BCG and Tuberculosis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global BCG and Tuberculosis Vaccine Sales Forecast by Application (2023-2028) & (Units)
    Table 89. Global BCG and Tuberculosis Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global BCG and Tuberculosis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global BCG and Tuberculosis Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Merck Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 93. Merck BCG and Tuberculosis Vaccine Product Offered
    Table 94. Merck BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 95. Merck Main Business
    Table 96. Merck Latest Developments
    Table 97. Japan BCG Lab Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 98. Japan BCG Lab BCG and Tuberculosis Vaccine Product Offered
    Table 99. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 100. Japan BCG Lab Main Business
    Table 101. Japan BCG Lab Latest Developments
    Table 102. Serum Institute of India Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 103. Serum Institute of India BCG and Tuberculosis Vaccine Product Offered
    Table 104. Serum Institute of India BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 105. Serum Institute of India Main Business
    Table 106. Serum Institute of India Latest Developments
    Table 107. AJ Vaccines Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 108. AJ Vaccines BCG and Tuberculosis Vaccine Product Offered
    Table 109. AJ Vaccines BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 110. AJ Vaccines Main Business
    Table 111. AJ Vaccines Latest Developments
    Table 112. BioFarma Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 113. BioFarma BCG and Tuberculosis Vaccine Product Offered
    Table 114. BioFarma BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 115. BioFarma Main Business
    Table 116. BioFarma Latest Developments
    Table 117. GreenSignal Bio Pharma Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 118. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Offered
    Table 119. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 120. GreenSignal Bio Pharma Main Business
    Table 121. GreenSignal Bio Pharma Latest Developments
    Table 122. China National Biotec Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 123. China National Biotec BCG and Tuberculosis Vaccine Product Offered
    Table 124. China National Biotec BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 125. China National Biotec Main Business
    Table 126. China National Biotec Latest Developments
    Table 127. Biomed Lublin Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 128. Biomed Lublin BCG and Tuberculosis Vaccine Product Offered
    Table 129. Biomed Lublin BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 130. Biomed Lublin Main Business
    Table 131. Biomed Lublin Latest Developments
    Table 132. Taj Pharmaceuticals Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 133. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Offered
    Table 134. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 135. Taj Pharmaceuticals Main Business
    Table 136. Taj Pharmaceuticals Latest Developments
    Table 137. Ataulpho de Paiva Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 138. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Offered
    Table 139. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 140. Ataulpho de Paiva Main Business
    Table 141. Ataulpho de Paiva Latest Developments
    Table 142. IVAC-Institute of Vaccines and Medical Biologicals Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 143. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Offered
    Table 144. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 145. IVAC-Institute of Vaccines and Medical Biologicals Main Business
    Table 146. IVAC-Institute of Vaccines and Medical Biologicals Latest Developments
    Table 147. Queen Saovabha Mem. Inst Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 148. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Offered
    Table 149. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 150. Queen Saovabha Mem. Inst Main Business
    Table 151. Queen Saovabha Mem. Inst Latest Developments
    Table 152. Microgen Basic Information, BCG and Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 153. Microgen BCG and Tuberculosis Vaccine Product Offered
    Table 154. Microgen BCG and Tuberculosis Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 155. Microgen Main Business
    Table 156. Microgen Latest Developments
List of Figures
    Figure 1. Picture of BCG and Tuberculosis Vaccine
    Figure 2. BCG and Tuberculosis Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global BCG and Tuberculosis Vaccine Sales Growth Rate 2017-2028 (Units)
    Figure 7. Global BCG and Tuberculosis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. BCG and Tuberculosis Vaccine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Immune Vaccine
    Figure 10. Product Picture of Therapy Vaccine
    Figure 11. Global BCG and Tuberculosis Vaccine Sales Market Share by Type in 2021
    Figure 12. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2017-2022)
    Figure 13. BCG and Tuberculosis Vaccine Consumed in Self-Procurement
    Figure 14. Global BCG and Tuberculosis Vaccine Market: Self-Procurement (2017-2022) & (Units)
    Figure 15. BCG and Tuberculosis Vaccine Consumed in UNICEF
    Figure 16. Global BCG and Tuberculosis Vaccine Market: UNICEF (2017-2022) & (Units)
    Figure 17. BCG and Tuberculosis Vaccine Consumed in Other
    Figure 18. Global BCG and Tuberculosis Vaccine Market: Other (2017-2022) & (Units)
    Figure 19. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
    Figure 20. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application in 2021
    Figure 21. BCG and Tuberculosis Vaccine Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global BCG and Tuberculosis Vaccine Revenue Market Share by Company in 2021
    Figure 23. Global BCG and Tuberculosis Vaccine Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global BCG and Tuberculosis Vaccine Revenue Market Share by Geographic Region in 2021
    Figure 25. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2017-2022)
    Figure 26. Global BCG and Tuberculosis Vaccine Revenue Market Share by Country/Region in 2021
    Figure 27. Americas BCG and Tuberculosis Vaccine Sales 2017-2022 (Units)
    Figure 28. Americas BCG and Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
    Figure 29. APAC BCG and Tuberculosis Vaccine Sales 2017-2022 (Units)
    Figure 30. APAC BCG and Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
    Figure 31. Europe BCG and Tuberculosis Vaccine Sales 2017-2022 (Units)
    Figure 32. Europe BCG and Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa BCG and Tuberculosis Vaccine Sales 2017-2022 (Units)
    Figure 34. Middle East & Africa BCG and Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
    Figure 35. Americas BCG and Tuberculosis Vaccine Sales Market Share by Country in 2021
    Figure 36. Americas BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2021
    Figure 37. United States BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC BCG and Tuberculosis Vaccine Sales Market Share by Region in 2021
    Figure 42. APAC BCG and Tuberculosis Vaccine Revenue Market Share by Regions in 2021
    Figure 43. China BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe BCG and Tuberculosis Vaccine Sales Market Share by Country in 2021
    Figure 50. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2021
    Figure 51. Germany BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa BCG and Tuberculosis Vaccine Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa BCG and Tuberculosis Vaccine Revenue Market Share by Country in 2021
    Figure 58. Egypt BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country BCG and Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of BCG and Tuberculosis Vaccine in 2021
    Figure 64. Manufacturing Process Analysis of BCG and Tuberculosis Vaccine
    Figure 65. Industry Chain Structure of BCG and Tuberculosis Vaccine
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global BCG and Tuberculosis Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global BCG and Tuberculosis Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global BCG and Tuberculosis Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports